– Premier, Inc., a technology-driven health care improvement company, has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital.
– The agreement has been unanimously approved by Premier’s Board of Directors.
– Premier stockholders will receive $28.25 per share in cash, representing a 23.8% premium to the company’s 60-day volume-weighted average price as of September 5, 2025.
– Richard Statuto, Premier’s Board Chair, emphasized that the Board believes the transaction is in the best interests of stockholders and will provide immediate value while granting the company access to additional capital.
– Michael J. Alkire, Premier’s President and CEO, noted that going private will enhance financial flexibility, accelerate product portfolio advancement, and support innovation in supply chain, technology, and advisory services.
– Patient Square Founding Partner Neel Varshney highlighted Premier’s innovation in essential services and expressed confidence in growing Premier’s supply chain, data, technology, and consulting offerings as a private company.
